Free UK Delivery on orders over £49

Fertipig Lyophilisate/solvent for solution for injection 5 Dose

Item Number: FERTIPIG

Fertipig Lyophilisate/solvent for solution for injection 5 Dose

Total: £0.00

Choose quantity to add to basket



Browse other products from the Ceva product range


Fertipig Lyophilisate and solvent for solution for injection for pigs.

In sows after weaning:

Induction and synchronisation of œstrus within 7 days following the treatment.

Reduction of the weaning to oestrus interval in sows with late oestrus.

Treatment of seasonal anoestrus.

Dosage and administration

Intramuscular use.

Dissolve the lyophilisate with a small quantity of solvent. Mix to obtain a homogenous solution. Transfer this solution into the vial that contains the rest of the solvent. Shake the vial well to obtain homogenous solution.

400 IU of equine serum gonadotrophin and 200 IU of chorionic gonadotrophin per animal, i.e. 5 ml of the reconstituted solution in one administration within 24 hours after the weaning.

Contra-indications, warnings, etc

Do not administer to pregnant animals.

Do not administer to animals with known hypersensitivity to the active substances or to any of the excipients.

Do not administer to sows with follicular cysts.

Special warnings

Treatment during the primary luteinised phase or in the middle of the cycle may increase the risk of development of ovarian cysts.

Do not adjust the dose. Increased doses do not increase the efficacy of the product.

Special precautions for use in animals

Do not inject into the subcutaneous fat.

Special precautions to be taken by the person administering the medicinal products to animals

Care should be taken to avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Wash hands after handling the product. The product can cause a slight skin irritation. When the product comes into contact with the skin, rinse immediately with plenty of water.

Pregnant women, women intending to become pregnant or whose pregnancy status is unknown, should not use the product due to the risk of unintended self injection. Studies in laboratory animals exhibited dose-dependent teratogenic effects after the administration of the combination HCG / PMSG.

People with known hypersensitivity to gonadotrophins should avoid contact with the product.

Packaging Quantities

Cardboard carton containing one vial of lyophilisate and one 25 ml vial solvent.

Cardboard carton containing ten vials of lyophilisate and ten 25 ml vials solvent.

Once reconstituted the product contains five doses (5 ml/dose).

Not all pack sizes may be marketed.

Data Sheets

FERTIPIG: Data Sheet